Bumjin Lim
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urology top 10%
- Urinary Bladder and Prostate Research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 15
- Renal cell carcinoma treatment 6
- Prostate Cancer Treatment and Research 6
- Urology 6
- Urological Disorders and Treatments 4
- Co-authors
- Choung‐Soo Kim (23 shared papers)In Gab Jeong (26 shared papers)Jun Hyuk Hong (24 shared papers)Dalsan You (22 shared papers)Bumsik Hong (16 shared papers)Yoon Soo Kyung (11 shared papers)Myung‐Soo Choo (2 shared papers)Miho Song (2 shared papers)
- Journals
- Prostate International (5 papers)Scientific Reports (4 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Clinical Genitourinary Cancer (2 papers)Medicine (2 papers)
- Partner nations
- South KoreaMalaysiaUnited States
In The Last Decade
Bumjin Lim
48 papers receiving 385 citations
Bumjin Lim's Hit Papers
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 186
- Urology 31
- Cancer Research 45
- Biotechnology 17
- Rheumatology 23
Countries citing papers authored by Bumjin Lim
This map shows the geographic impact of Bumjin Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bumjin Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bumjin Lim more than expected).
Fields of papers citing papers by Bumjin Lim
This network shows the impact of papers produced by Bumjin Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bumjin Lim. The network helps show where Bumjin Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Bumjin Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study Hit paper breakdown → | 2024 | 97 |
| 2 | 2021 | 20 | |
| 3 | 2014 | 19 | |
| 4 | 2023 | 16 | |
| 5 | 2024 | 16 | |
| 6 | 2014 | 15 | |
| 7 | 2020 | 15 | |
| 8 | 2015 | 13 | |
| 9 | 2015 | 13 | |
| 10 | 2019 | 12 | |
| 11 | 2020 | 12 | |
| 12 | 2020 | 11 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 9 | |
| 17 | 2022 | 9 | |
| 18 | 2024 | 9 | |
| 19 | 2020 | 7 | |
| 20 | 2015 | 6 |
About Bumjin Lim
Bumjin Lim is a scholar working on Pulmonary and Respiratory Medicine, Urology, Surgery, Biotechnology and Oncology, having authored 56 papers that have together received 393 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (15 papers), Bladder and Urothelial Cancer Treatments (13 papers), Renal cell carcinoma treatment (6 papers), Prostate Cancer Treatment and Research (6 papers), Urological Disorders and Treatments (4 papers), Microbial Inactivation Methods (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Radiation Effects and Dosimetry (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (186 citations), Urology (31 citations), Cancer Research (45 citations), Biotechnology (17 citations) and Rheumatology (23 citations). Bumjin Lim has collaborated with scholars based in South Korea, Malaysia and United States. Frequent co-authors include Choung‐Soo Kim, In Gab Jeong, Jun Hyuk Hong, Dalsan You, Bumsik Hong, Yoon Soo Kyung, Myung‐Soo Choo, Miho Song, Won‐Chul Lee and Hanjong Ahn. Their work appears in journals such as Prostate International, Scientific Reports, Journal of Cancer Research and Clinical Oncology, Clinical Genitourinary Cancer and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.